The comprehensive molecular analyses of breast cancer tumours have demonstrated a subset of TNBC resembling molecular apocrine or luminal androgen receptor (LAR) tumours with androgen receptor activation and its downstream effects [53]. Here, AR is linked to breast carcinoma.